JP Morgan Chase’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-364,614
| Closed | -$4.17M | – | 6561 |
|
|
2020
Q4 | $4.17M | Buy |
364,614
+14,262
| +4% | +$162K | ﹤0.01% | 2967 |
|
|
2020
Q3 | $2.34M | Sell |
350,352
-18,297
| -5% | -$120K | ﹤0.01% | 3131 |
|
|
2020
Q2 | $2.4M | Sell |
368,649
-150,038
| -29% | -$969K | ﹤0.01% | 2986 |
|
|
2020
Q1 | $3.43M | Buy |
518,687
+119,925
| +30% | +$1.05M | ﹤0.01% | 2560 |
|
|
2019
Q4 | $4.14M | Sell |
398,762
-207,054
| -34% | -$1.77M | ﹤0.01% | 2836 |
|
|
2019
Q3 | $3.83M | Sell |
605,816
-157,886
| -21% | -$1.18M | ﹤0.01% | 2909 |
|
|
2019
Q2 | $5.32M | Buy |
763,702
+84,361
| +12% | +$556K | ﹤0.01% | 2582 |
|
|
2019
Q1 | $4.17M | Sell |
679,341
-3,650
| -0.5% | -$42.3K | ﹤0.01% | 2731 |
|
|
2018
Q4 | $7.87M | Sell |
682,991
-8,564
| -1% | -$146K | ﹤0.01% | 2213 |
|
|
2018
Q3 | $15M | Buy |
691,555
+12,549
| +2% | +$237K | ﹤0.01% | 1879 |
|
|
2018
Q2 | $10.7M | Sell |
679,006
-75,945
| -10% | -$1.19M | ﹤0.01% | 2087 |
|
|
2018
Q1 | $14.2M | Buy |
754,951
+191,589
| +34% | +$3.78M | ﹤0.01% | 1772 |
|
|
2017
Q4 | $9.8M | Buy |
563,362
+492,512
| +695% | +$6.8M | ﹤0.01% | 2145 |
|
|
2017
Q3 | $1.06M | Sell |
70,850
-1,400
| -2% | -$22K | ﹤0.01% | 3490 |
|
|
2017
Q2 | $1.34M | Buy |
72,250
+68,950
| +2,089% | +$1.2M | ﹤0.01% | 3273 |
|
|
2017
Q1 | $56K | Sell |
3,300
-5,328
| -62% | -$106K | ﹤0.01% | 4503 |
|
|
2016
Q4 | $184K | Sell |
8,628
-63,569
| -88% | -$1.3M | ﹤0.01% | 4218 |
|
|
2016
Q3 | $1.32M | Sell |
72,197
-62,950
| -47% | -$1.42M | ﹤0.01% | 3006 |
|
|
2016
Q2 | $3.92M | Buy |
+135,147
| New | +$3.76M | ﹤0.01% | 2435 |
|
JP Morgan Chase's ARA Position: Q1 2021 in Review
JP Morgan Chase sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 364,614 shares — an estimated $4.17M sold.
JP Morgan Chase first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $15M in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- JP Morgan Chase reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- JP Morgan Chase sold 364,614 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $4.17M.
- JP Morgan Chase first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- JP Morgan Chase's American Renal Associates Holdings, Inc position peaked at $15M in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.